Author(s):
Saniya A. Mulla, B. P. Chaudhari, V. K. Redasani, Nikita Sawant
Email(s):
saniyamulla395@gmail.com
DOI:
10.52711/2231-5659.2025.00040 
Address:
Saniya A. Mulla*, B. P. Chaudhari, V. K. Redasani, Nikita Sawant
YSPM’s Yashoda Technical Campus, Faculty of Pharmacy, Wadhe, Satara, Maharashtra, India.
*Corresponding Author
Published In:
Volume - 15,
Issue - 3,
Year - 2025
ABSTRACT:
To guarantee the highest degree of patient satisfaction, pharmaceutical tablet quality is crucial. Safety, potency, efficacy, stability, patient acceptability, and regulatory compliance are the most crucial factors in determining the quality of tablet form. The quality, bioavailability, and ideal therapeutic activity of pharmaceutical tablets can be guaranteed by a variety of quality control factors. Enabling in-process and final product quality control methods helps all pharmaceutical firms realize their goal of producing high-quality products. Assuring that the intermediates, packaging materials, and final pharmaceutical tablets meet approved specifications involves in-process quality control, which encompasses concepts that are implemented before, after, and during production covering all steps, including specification establishment, sampling, pertinent testing, and analytical clearance. In order for a value to be considered acquiescent according to the standards, it must fall within the various stated limitations provided by various pharmacopoeias. Therefore, an attempt is made to communicate the harmonized limitations through pharmacopoeia comparisons in order to ensure that the goods fulfill the specifications as outlined in the pharmacopoeias, thereby verifying the quality of pharmaceutical dosage forms. This study aims to give brief details on pharmaceutical capsule quality control testing, both in-process and final, in accordance with various pharmacopoeias.
Cite this article:
Saniya A. Mulla, B. P. Chaudhari, V. K. Redasani, Nikita Sawant. IPQC and FPQC test for Tablet. Asian Journal of Research in Pharmaceutical Sciences. 2025; 15(3):268-4. doi: 10.52711/2231-5659.2025.00040
Cite(Electronic):
Saniya A. Mulla, B. P. Chaudhari, V. K. Redasani, Nikita Sawant. IPQC and FPQC test for Tablet. Asian Journal of Research in Pharmaceutical Sciences. 2025; 15(3):268-4. doi: 10.52711/2231-5659.2025.00040 Available on: https://ajpsonline.com/AbstractView.aspx?PID=2025-15-3-7
REFERENCE:
1. Dibyajyoti Saha, Milan Hait, Mayukh Jana, Suprodip Mandal, Utpal Jana. Radiopharmaceuticals and Radio Opaque Contrast Media: Practice, Prospects and Potentials. Asian J. Res. Pharm. Sci. 2011; 1(1): 04-08.
2. Gupta VN and Kumar VP. A Review on quality by design approach (QBD) for Pharmaceuticals. International Journal of Drug Development and Research. 2015; 7(1): 52-60.
3. Woodcock J. The concept of pharmaceutical quality. American Pharmaceutical Review. 2004; 7(60): 10-15.
4. Pradeep Sahu, Neha Pinkalwar, Ravindra Dhar Dubey, Shweta Paroha, Shilpi Chatterjee, Tanushree Chatterjee. Biomarkers: An Emerging Tool for Diagnosis of a Disease and Drug Development. Asian J. Res. Pharm. Sci. 2011; 1(1): 09-16.
5. JM Fortunak1; RD Souza; AA Kulkarni; CL King; T Ellison; LSM Miranda, Antivi. Thera. 2014; 19(3): 4-6.
6. T Mehmood; MR Salaria; GM Herani; MA Qureshi, Ind. J. of Manage. and Soci. Sci. 2009; 3(2): 21-30.
7. Mittal A, Priyadarshani K, Rathore RPS and Abhilasha. A Review on Comparative Study of In-process and Finished Product Quality Control Test for Sterile and Non-Sterile Dosage Form. International Journal of Institutional Pharmacy and Life Sciences. 2015; 5(2): 52-65.
8. Pramod Patil, Someshwara Rao B, Suresh V Kulkarni, Basavaraj, Chetan Surpur, Anand Ammanage. Formulation and In Vitro Evaluation of Floating Matrix Tablets of Ofloxacin. Asian J. Res. Pharm. Sci. 2011; 1(1): 17-22.
9. Aulton ME. Pharmaceutics-The science of dosage form design, Second edition. Churchill Livingstone. 2001
10. Sourabh S. Baghel, Sonal Dangi, Prashant Soni, Priya Singh, Yogesh Shivhare. Acute Toxicity Study of Aqueous Extract of Coccinia indica (Roots). Asian J. Res. Pharm. Sci. 2011; 1(1): 23-25.
11. World Health Organization. WHO Technical Report Series, No. 961, 48th Report, Annex 3. World Health Organization, Geneva. 2011
12. Swati Rawat, Akhilesh Gupta. Development and Study of Wound Healing Activity of an Ayurvedic Formulation. Asian J. Res. Pharm. Sci. 2011; 1(1): 26-28.
13. Teja CH, Balamuralidhara V, Vinay S, Bhat RS and TMP Kumar. Comparative study of in-process and finished products quality control test of Indian Pharmacopoeia, British Pharmacopoeia, United State Pharmacopoeia for capsule and liquid orals. International Research Journal of Pharmacy. 2011; 2(9): 65-69.
14. Jatto E, Okhamafe AO. An overview of pharmaceutical validation and process controls in drug development. Trop J Pharm Res. 2002; 1(2): 116-117.
15. Dibyajyoti Saha, Ankit Tamrakar. Xenobiotics, Oxidative Stress, Free Radicals Vs. Antioxidants: Dance Of Death to Heaven’s Life. Asian J. Res. Pharm. Sci. 2011; 1(2): 36-38.
16. Merlin N.J., Arya. River Blindness – An Eye Disorder. Asian J. Res. Pharm. Sci. 2011; 1(2): 39-41.
17. Sandeep B. Patil, Chandrakant S. Magdum. Determination of LC50 Values of Extracts of Euphorbia hirta Linn and Euphorbia neriifolia Linn Using Brine Shrimp Lethality Assay. Asian J. Res. Pharm. Sci. 2011; 1(2): 42-43.
18. Celik, M. Overview of compaction data analysis techniques. Drug Dev Ind Pharm.1922; 18: 767-810.
19. Hiestand EN, Wells JE, Poet CB, Ochs JF. Physical processes of tableting. J Pharm Science. 1977; 66: 510-519.
20. Srujana N, Balachandra PM, Venkatesh MP, Balamuralidhara V, Kumar TMP. A comparative study of in-process and finished products quality control tests for ophthalmic products in different pharmacopoeias. Int J of Pharma Teach & Prac. 2012; 3(2): 261-262.
21. J. Kasthuri, A. Cholarajan, R. Vijayakumar, P. Muthukumaran. Physico-chemical and Microbial Analysis of Coir Industry Effluent. Asian J. Res. Pharm. Sci. 2011; 1(2): 44-46.
22. MS Amran. Introduction to Pharmacy, 2nd Edition, Krishnochura Prokashoni, Dhaka. 2015: 20-50.
23. L Lachman, HA Lieberman, and JL Kanig: The Theory and Practice of Industrial Pharmacy, Varghese Publishing House 3rd Edition. 1986; 296-300.
24. P Tangri, P Mamgain, Shaffi, AML Verma, and Lakshmayya International. Journal of Indian. Pharmacy and Bio Sciences. 2014; 1(1): 49-51.
25. Mazumder B, Bhattacharya S, and Yadav A: Total Quality Management in Pharmaceuticals: A Review. 2011; 3: 365- 375
26. LVA Jr. Remington Introduction to Pharmacy, 1st Edition, Pharmaceutical Press, UK, 2013, 146.
27. European Medicines Agency. International Conference on Harmonisation (ICH) Guidelines Q3B (R2). Impurities in New drug Products. European Medicines agency, U.K. 2006
28. Allen LV. Remington: An Introduction to Pharmacy First edition. Pharmaceutical Press Lambeth High Street, London. 2013; 146.
29. Jr. LVA and Ansel HC. Ansel’s Pharmaceutical Dosage Forms and Drug Delivery Systems, Tenth edition, Baltimore, Philadelphia. 2014; 271.
30. United State Pharmacopoeia 40-National Formulary 35. Thirty-Five edition. United State Pharmacopoeia Convention, Stationery Officer, USA. 2017
31. Unites States Pharmacopoeia Convention. United States Pharmacopoeia 38-National Formulary 33, Stationery Office, USA, 2010
32. British Pharmacopoeia Commission. British Pharmacopoeia, 13th Edition, Stationery Office, Great Britain, 2013
33. Indian Pharmacopoeia Commission. Indian Pharmacopoeia. 7th edition, Ghaziabad: Indian Pharmacopoeia Commission; 2007
34. Indian Pharmacopoeia, Government of India, Ministry of Health and family Welfare. Eight edition. The Indian Pharmacopoeia Commision, Gaziabad, India. 2018
35. World Health Organization. (2003). The International Pharmacopoeia. World Health Organization, Geneva.
36. Sandeep B. Patil, Nilofar S. Naikwade, Chandrakant S. Magdum, Vikas B. Awale. Centrally Acting Analgesic Activity and CNS Depressant Activity of Cajanus cajan Linn. Asian J. Res. Pharm. Sci. 2011; 1(2): 50-51.